Company Overview
Snapshot
Founded in January 2021 by Dr. Ettie Maman, Rohi Hourvitz, Prof. Ariel Hourvitz, and Dr. Micha Baum, FertilAI operates with 11–50 employees. The company has raised $4.54 million across two funding rounds from three investors. In April 2026, FertilAI received CE marking under the EU Medical Device Regulation for its AI-driven clinical decision support tools.
Business overview
FertilAI develops AI algorithms aimed at enhancing the success rates of fertility treatments by improving workflow management between doctors and patients. The company's core technology focuses on predictive AI for natural cycle ovulation prediction, which has already been developed based on clinical research. FertilAI serves the health tech and life sciences sectors, specifically targeting clinics, hospitals, and gynecology practices with its SaaS-based decision support and digital healthcare solutions.
Strategic signal
In April 2026, FertilAI secured CE marking under the EU Medical Device Regulation for its AI-driven clinical decision support tools. This regulatory approval is a significant validation of the company's technology and its potential to be deployed across European markets, signaling strong commercialization potential and a competitive edge in the medical device and digital health landscape.
Log in to access full profile ›Company Intelligence Q&A
- What is FertilAI's primary focus?
- FertilAI focuses on developing AI algorithms to increase the success rates of fertility treatments, with an emphasis on improving workflows between medical professionals and patients.
- When was FertilAI founded and by whom?
- FertilAI was founded in January 2021 by Dr. Ettie Maman, Rohi Hourvitz, Prof. Ariel Hourvitz, and Dr. Micha Baum.
- What significant regulatory milestone did FertilAI achieve?
- In April 2026, FertilAI received CE marking under the EU Medical Device Regulation (EU MDR) for its AI-driven clinical decision support tools, specifically for predictive AI in fertility treatment cycle optimization.
- Has FertilAI received any grants?
- In January 2021, FertilAI secured a grant from the Israel Innovation Authority to develop a first pilot site.
- Which investors participated in FertilAI's November 2024 funding round?
- In November 2024, FertilAI raised funding from Redseed and Longevity Venture Partners.